Digital Pathology Market: Current Analysis and Forecast (2021-2027)

Region:Global

Author(s):

Product Code:UMHE21878

Download Sample Report download
Buy the Full ReportStarting from $3999
Published on

June 2022

Total pages

212

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $3999

About the Report

About the Report

The digital pathology market is expected to register a CAGR of around 10% over the period of 2021-2027. Digital pathology is a practice of pathology using digital imaging. The application of this breakthrough technology is ready to become the standard of care in the field of pathology. Digital pathology uses still images, live streaming of images, and more recently whole slide images (WSI). Clinical applications include making primary pathological diagnoses directly from digital images, remote pathology, archiving, and image analysis. Non-clinical applications include skills testing, research, and education. The growing adoption of digital pathology can be attributed to the rising prevalence of cancer coupled with a rapidly growing geriatric population. According to the United Nations, the 60+ aged population was 962 million in 2017 which is more than twice that it was in 1980 at 382 million. The number of elderly is expected to double again by 2050 and reach nearly 2.1 billion worldwide. Furthermore, the digital pathology market is anticipated to grow on account of the growing technological advancement, and demand for enhancing lab efficiency.

Based on product type, the market is classified into the scanner, software, and storage system. Amongst them, the scanner category accounted for a significant share of the market. The increase in R&D activities in the pharmaceutical & medical device industry and the surge in adoption of digital pathology systems contribute to the growth of the segment.

Based on application, the market is classified into teleconsultation, training, disease diagnosis, and drug discovery. The drug discovery category accounted for a significant share of the market due to an increase in the prevalence of rare diseases and growing R&D activities in the drug development process.

Based on end-users, the market is classified into pharmaceutical & biotechnology companies, academic and research, and hospitals. The pharmaceutical & biotechnology companies category accounted for a considerable share of the digital pathology market. The growth of this segment can be attributed to the growing adoption of digital pathology for drug discovery studies and drug toxicology testing.

For a better understanding of the market adoption of digital pathology market, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the digital pathology industry and generated major revenue in 2020 owing to the presence of well-established market players and the increasing prevalence of cancer in the region.

Some of the major players operating in the market include 3dhistech Ltd., Danaher Corporation (Leica Microsystem), Glencoe Software Inc., Hamamatsu Photonics K.K., Indica Labs Inc., Koninklijke Philips N.V., Nikon Corporation, Perkinelmer Inc., F- Hoffmann La-Roche, Visiopharm A/S.

Products


Companies

3dhistech Ltd., Danaher Corporation (Leica Microsystem), Glencoe Software Inc., Hamamatsu Photonics K.K., Indica Labs Inc., Koninklijke Philips N.V., Nikon Corporation, Perkinelmer Inc., F- Hoffmann La-Roche, Visiopharm A/S

Table of Contents

Table of Contents

1 MARKET INTRODUCTION

1.1. Market Definitions

1.2. Limitation

1.3. Stakeholders

1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Digital Pathology Market

2.2. Research Methodology of the Digital Pathology Market

2.3. Forecasting Method

2.4. Respondent Profile

2.5. Main Objective of the Digital Pathology Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL DIGITAL PATHOLOGY MARKET COVID-19 IMPACT

6 GLOBAL DIGITAL PATHOLOGY MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY PRODUCT TYPE

7.1. Scanner

7.2. Software

7.3. Storage System

8 MARKET INSIGHTS BY TYPE

8.1. Human

8.2. Veterinary

9 MARKET INSIGHTS BY APPLICATION

9.1. Teleconsultation

9.2. Training

9.3. Disease Diagnosis

9.4. Drug Discovery

10 MARKET INSIGHTS BY END-USERS

10.1. Pharmaceutical & Biotechnology Companies

10.2. Academic and research

10.3. Hospitals

11 MARKET INSIGHTS BY REGION

11.1. North America Digital Pathology Market

11.1.1. United States

11.1.2. Canada

11.1.3. Rest of North America

11.2. Europe Digital Pathology Market

11.2.1. Germany

11.2.2. France

11.2.3. United Kingdom

11.2.4. Italy

11.2.5. Spain

11.2.6. Rest of Europe

11.3. Asia Pacific Digital Pathology Market

11.3.1. China

11.3.2. Japan

11.3.3. India

11.3.4. Australia

11.3.5. Rest of Asia Pacific

11.4. Rest of World Digital Pathology Market

12 DIGITAL PATHOLOGY MARKET DYNAMICS

12.1. Market Drivers

12.2. Market Challenges

12.3. Impact Analysis

13 DIGITAL PATHOLOGY MARKET OPPORTUNITIES

14 DIGITAL PATHOLOGY MARKET TRENDS

15 LEGAL & REGULATORY FRAMEWORK

16 DEMAND AND SUPPLY SIDE ANALYSIS

16.1. Demand Side Analysis

16.2. Supply Side Analysis

17 VALUE CHAIN ANALYSIS

18 COMPETITIVE SCENARIO

18.1. Competitive Landscape

18.1.1. Porter's Five Forces Analysis

19 COMPANY PROFILED

19.1. 3dhistech Ltd.

19.2. Danaher Corporation (Leica Microsystem)

19.3. Glencoe Software, Inc.

19.4. Hamamatsu Photonics K.K.

19.5. Indica Labs Inc.

19.6. Koninklijke Philips N.V.

19.7. Nikon Corporation

19.8. Perkinelmer Inc.

19.9. F- Hoffmann La-Roche (Roche)

19.10. Visiopharm A/S

20 DISCLAIMER

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022